Note: Boundless Bio's revenues are gauged from an analysis of company filings.
Boundless Bio's Income Statement (based on Industry Averages)
Boundless Bio P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Boundless Bio has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
August 15, 2023
26
100%
$100 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Boundless Bio is developing and marketing.
Boundless Bio doesn't have any recent trademark applications, indicating Boundless Bio is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ECHO Providing online non-downloadable computer software for use in the identification and treatment of cancers driven by extrachromosomal DNA (ecDNA) amplification; providing online non-downloadable computer software for use in identifying ecDNA, namely, by using data analysis algorithms, imaging data, and sequencing data; scientific research services in the field of diagnostic and therapeutic agents, preparations and substances for the identification and treatment of cancers driven by or associated with extrachromosomal DNA (ecDNA) amplification using machine learning on data obtained from clinical samples
12/07/2021
UNBOUND BY CONVENTION, BOUND TO SAVE LIVES scientific research consulting services in the field of diagnostic and therapeutic agents, preparations and substances for the identification and treatment of cancers driven by extrachromosomal DNA (ecDNA) amplification; medical research and analysis services in the field of diagnostic and therapeutic agents, preparations and substances for the identification and treatment of cancers driven by extrachromosomal DNA (ecDNA) amplification; scientific research related to the identification and treatment of cancers driven by extrachromosomal DNA (ecDNA) amplification; medical research in the nature of identification and development of agents, preparations and substances for treatment of cancers driven by extrachromosomal DNA (ecDNA) amplification
08/28/2019
See all trademarks and details in the Full Report.
Market Share of Boundless Bio's Largest Competitors
A competitive analysis shows these companies are in the same general field as Boundless Bio, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Boundless Bio.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Boundless Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.